AllQuantitative Report
logoArgusApril 14, 2021

VCEL: Rating decreased to a HOLD

Symbols
VCEL
Sector(s)
Healthcare
Rating
Current Price
$50.77
Price Target
$NaN
Earnings Estimate
Summary

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company dedicated to the identification, development, and commercialization of innovative therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free